AAFIYAH SOLUTIONS INC NPI 1851936132

NPI Details

AAFIYAH SOLUTIONS INC is a community/retail pharmacy pharmacy in Hoffman Estates, IL. The provider is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes. AAFIYAH SOLUTIONS INC NPI is 1851936132. The provider is registered as an organization entity type.
The provider Is Doing Business As Galaxy Medical Lab.

The provider's business location address is:

1041 W GOLF RD
HOFFMAN ESTATES, IL
ZIP 60169-339
Phone: (847) 764-8992
Fax: (847) 764-8993

The provider's authorized official is Khuteja Begum .
The authorized official title is Pharmacist and has the following contact phone number (480) 299-8147.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home (HCPCS:M0201)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)

The enumeration date for this NPI number is 11/11/2019 and was last updated on 2/7/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: